Upper Limb Movement
All ONWARD® Medical therapies are investigational and not available for commercial use.
Discover Our Therapy
Discover Our Therapy
External Platform
External Platform
Discover The Potential Benefits
ARCEX is designed to help people with spinal cord injury regain more control over their day.
Discover The Potential Benefits
ARCEX is designed to help people with spinal cord injury regain more control over their day.
Arm and hand movement
Dexterity and finger control
Sensation
“When we talk about 10% more function, we think about how important that is in terms of being able to live a life. That little bit more independence allows you to do so much more.”
Jessie Owen
ARCEX Therapy trial participant
Read Our Publications
Read The Evidence
The results from our Up-LIFT pivotal trial were published in Nature Medicine, one of the world’s preeminent scientific journals.
The Up-LIFT study evaluated the safety and effectiveness of non-invasive electrical spinal cord stimulation (ARCEX Therapy) to improve upper limb mobility in people with chronic incomplete tetraplegia. The clinical study enrolled 65 people at 14 leading SCI centers in the US, Europe, and Canada.
Highlights* include:
Primary safety and effectiveness endpoints met.
90% of participants improved strength or function of their upper limbs.
87% of participants reported improvement in quality of life.
Improvement was demonstrated in participants up to 34 years post-injury.
All ONWARD® Medical devices and therapies referenced here, including but not limited to ARCIM®, ARCEX®, ARCBCI™, and ARC Therapy™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.
*Moritz, Chet, et al. “Non-invasive spinal cord stimulation for arm and hand function in chronic tetraplegia: a safety and efficacy trial.” Nature Medicine. 2024.